Randomized Trial of Medical versus Surgical Treatment for Refractory Heartburn
Stuart J. Spechler(VA North Texas Health Care System), John G. Hunter(Oregon Health & Science University), Karen Jones(VA North Texas Health Care System), Robert Lee(VA North Texas Health Care System), Brian R. Smith(VA North Texas Health Care System), Hiroshi Mashimo(Harvard University), Vivian M. Sanchez(Boston University), Kerry B. Dunbar(VA North Texas Health Care System), Thai Pham(VA North Texas Health Care System), Uma K. Murthy(VA North Texas Health Care System), Taewan Kim(VA North Texas Health Care System), Christian S. Jackson(University of Maryland, Baltimore), Jason Wallen(VA North Texas Health Care System), Erik C. von Rosenvinge(VA North Texas Health Care System), Jonathan P. Pearl(VA North Texas Health Care System), Loren Laine(Yale University), Anthony W. Kim(University of Southern California), Andrew M. Kaz(VA North Texas Health Care System), Roger P. Tatum(VA North Texas Health Care System), Ziad F. Gellad(VA North Texas Health Care System), Sandhya Lagoo‐Deenadayalan(VA North Texas Health Care System), Joel H. Rubenstein(Southwestern Medical Center), Amir A. Ghaferi(Southwestern Medical Center), Wai–Kit Lo(Harvard University), Ronald Fernando(University of Maryland, Baltimore), Bobby S. Chan(University of Maryland, Baltimore), Shirley Paski(VA North Texas Health Care System), Dawn Provenzale(VA North Texas Health Care System), Donald O. Castell(Medical University of South Carolina), David Lieberman(Oregon Health & Science University), Rhonda F. Souza(VA North Texas Health Care System), William D. Chey(Southwestern Medical Center), Stuart Warren(VA North Texas Health Care System), Anne Davis‐Karim(VA North Texas Health Care System), Shelby D. Melton(Southwestern Medical Center), Robert M. Genta(Oregon Health & Science University), Tracey Serpi(VA North Texas Health Care System), Kousick Biswas(VA North Texas Health Care System), Grant D. Huang(VA Office of Research and Development)
Cited by 261Open Access
Abstract
Heartburn that persists despite proton-pump inhibitor (PPI) treatment is a frequent clinical problem with multiple potential causes. Treatments for PPI-refractory heartburn are of unproven efficacy and focus on controlling gastroesophageal reflux with reflux-reducing medication (e.g., baclofen) or antireflux surgery or on dampening visceral hypersensitivity with neuromodulators (e.g., desipramine).
Related Papers
No related papers found
Powered by citation graph analysis